# 180 Life Sciences (stock symbol: ATNF) Logo in transparent PNG format

## 180 Life Sciences Logo large

### 180 Life Sciences Logo large Download PNG (6.3 KB)

![180 Life Sciences Logo large Download PNG (6.3 KB)](/img/orig/ATNF_BIG-fdd35e63.png)

## 180 Life Sciences Logo icon format

### 180 Life Sciences Logo icon format Download PNG (3.89 KB)

![180 Life Sciences Logo icon format Download PNG (3.89 KB)](/img/orig/ATNF-d05db139.png)

## About 180 Life Sciences

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

1. Website domain: 180lifesciences.com
2. Marketcap: $4.76 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
